$7.08
-0.37-4.97%
al cierre: Aug 17, 5:00 PM EST
$7.00
-0.45-6.02%
Premercado: 7:22 AM EST
Capricor Therapeutics Inc
CAPRNASDAQ
Ganancias: Los beneficios de Q2 2026 se publicaron el jue ago 13th, después del cierre del mercado
Conferencia telefónica: La conferencia telefónica más reciente comenzó a las 4:30 p. m., hace 6 díasHaz clic para ver el webcast
Capricor Therapeutics Earnings & Forecasts
Capricor Therapeutics (CAPR) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
Capricor Therapeutics Guidance
Recent Earnings Results
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.58 | $-0.54 | $-0.53 | $-0.54 |
| Actual | $-0.70 | $-0.59 | $-0.62 | $-0.54 |
| Surprise | -20.7% | -9.26% | -17.0% | 0.00% |
| Revenue | ||||
| Estimate | — | $25.2M | $1.7M | $1.2M |
| Actual | $0 | $0 | $0 | $0 |
| Surprise | — | -100.0% | -100.0% | -100.0% |
Analyst Estimates — Forward PeriodsSource: Wall Street consensus
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-0.43 | $-0.03 | $-0.40 | $-0.37 |
| Revenue | ||||
| Consensus | $10.4M | $22.0M | — | — |